WebIndustry: Biotech & Pharmaceuticals. Revenue: $100 to $500 million (USD) Competitors: Johnson & Johnson, Siemens, Roche. Create Comparison. Headquartered in Italy, DiaSorin is a global leader in the field of biotechnologies. For over 40 years the company has been developing, producing and marketing reagent kits for in vitro diagnostics worldwide. WebDiaSorin is an Italian multinational biotechnology company that produces and markets in vitro diagnostics reagent kits used in immunodiagnostics and molecular diagnostics and since July 2024, it is also active in the Life Science business. The group was founded in 2000 and is headquartered in Saluggia, Italy.Its production is at several plants located in …
DiaSorin to acquire Luminex Corporation for USD 37.00 per share or
WebMay 13, 2024 · CFIUS and Industrial Security Partner Antonia Tzinova spoke with The Capitol Forum about an Italian diagnostics company's planned buyout of an American medical test maker that is expected to face a detailed U.S. security probe. The Committee on Foreign Investment in the United States (CFIUS) will likely examine whether the … WebMar 20, 2024 · (Alliance News) - DiaSorin Spa announced Friday that it has received clearance from the U.S. Food and Drug Administration for the Simplexa Covid-19 & Flu A/B Direct test. The test detects and differentiates influenza type A and B and SARS-CoV-2 viruses, providing physicians with the information they need to determine the most … highway cams sunshine coast
DiaSorin: Overvalued Italian Healthcare Company (OTCMKTS:DSRLF)
WebApr 11, 2024 · Cybersecurity. Geopolitica. Banche centrali. Private Equity. Inflazione. Leader della finanza. Settori. Le notizie più lette. Notizie più rilevanti. ... Borsa Milano in rialzo dopo pausa pasquale, corre Lazio, bene auto, oil, Diasorin Oggi alle 10:28 Condividi MILANO (Reuters) - Partenza sprint a Piazza Affari, alla ripresa dopo il lungo ... WebJul 15, 2024 · With 900 clients, Luminex develops biological testing technologies. Credit: Darko Stojanovic from Pixabay. Italian diagnostics firm DiaSorin has concluded the acquisition of Luminex in an all-cash … WebApr 12, 2024 · The deal, which grows DiaSorin’s footprint in the key U.S. market, follows a similar acquisition by diagnostics rival Roche, which bought GenMark Diagnostics in a $1.8 billion deal to fill a ... highway cams vancouver